In this review, the authors discuss “actinopathies” in terms of the clinical aspects and cellular mechanisms, with a focus on the effect of these mutations on neutrophil function.…
Steven Quay, MD, PhD, physician-scientist and CEO of Atossa Therapeutics, discusses ongoing clinical trials of two treatments for patients infected with SARS-CoV-2 and how certain therapeutics will continue…
Mark Ballow, MD, of the University of South Florida, and Jolan Walter, MD, PhD, of the University of South Florida and Johns Hopkins All Children’s Hospital, discuss COVID-19…
In this review published in Nutrients, the authors discuss the importance of magnesium for the immune system and in the setting of infectious diseases. Reduced magnesium intake has…
Jolan Walter, MD, PhD, division chief of the University of South Florida (USF) and Johns Hopkins All Children’s Pediatric Allergy & Immunology Programs, discusses the importance of long-term…
The Covid-19 Early Treatment Fund was launched to provide funding for research in order to "find an existing drug or drug combination that, when given early, reduces hospitalization…
In this HemaSphere review, researchers share details about recent progress related to gene therapy technologies and procedures for primary immunodeficiency. Transduction of hematopoietic stem cells using lentiviral vectors…
In a study of 12 adults with primary immunodeficiency and gastrointestinal distress, in-depth interviews were used to explore their experiences and the actions they take to relieve GI…
The phase 3 Clinical Assessment of phaRmacokinetics, Efficacy, Safety of a 10% Ig (CARES10) study was designed to evaluate the safety, efficacy, and pharmacokinetics of a 10% intravenous immunoglobulin in…
In a study designed to analyze and improve the diagnostic sensitivity and specificity of the immunodeficiency disease-related scoring system in adult patients referred to immunology with clinical suspicion…
